(Prototype team page) |
|||
(14 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | {{Mingdao}} | + | {{:Team:Mingdao/test9}} |
− | <html> | + | <html lang="en"> |
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <link href='https://fonts.googleapis.com/css?family=Arizonia' rel='stylesheet'> | ||
+ | <link href='https://fonts.googleapis.com/css?family=Open+Sans' rel='stylesheet'> | ||
+ | <title>Description</title> | ||
+ | </head> | ||
+ | <style type="text/css"> | ||
+ | * { | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | box-sizing: border-box; } | ||
− | + | body { | |
− | + | width: 100%; | |
− | + | margin: 0; | |
− | + | padding: 0; | |
− | + | font-family: 'Ubuntu' !important; } | |
− | + | .bg-container { | |
+ | background-attachment: fixed; | ||
+ | overflow: hidden; | ||
+ | position: relative; | ||
+ | background-image: url(https://static.igem.org/mediawiki/2018/b/b7/T--Mingdao--ModelingBackground.jpg); | ||
+ | background-repeat: no-repeat; | ||
+ | background-size: 100%; | ||
+ | background-position: center; | ||
+ | } | ||
+ | .my-main-container { | ||
+ | width: 103.4%; | ||
+ | padding: 50px 7%; | ||
+ | } | ||
+ | .main-content { | ||
+ | background-color: rgba(255,255,255, .7); | ||
+ | width: 75%; | ||
+ | margin-left: 11%; | ||
+ | padding: 50px; | ||
+ | min-height: 180vh; | ||
+ | z-index: 10; | ||
+ | margin-top:600px;} | ||
− | + | .text-area { | |
+ | margin-bottom: 80px; } | ||
+ | .text-area h1 { | ||
+ | font-size: 130px; | ||
+ | font-weight: 700; | ||
+ | font-family: 'Arizonia' !important; | ||
+ | text-align: center; | ||
+ | margin-bottom: 1rem; } | ||
+ | .text-area p { | ||
+ | font-size: 22px; | ||
+ | font-weight: 500; } | ||
− | + | .m-block img { | |
− | + | width: 100%; } | |
− | <p> | + | .path-btns { |
− | + | position: fixed; | |
+ | width: 250px; | ||
+ | top: 200px; | ||
+ | left: 225px; } | ||
+ | .path-btns .path-dot { | ||
+ | width: 25px; | ||
+ | height: 25px; | ||
+ | border-radius: 50%; | ||
+ | position: absolute; | ||
+ | background-color: #fff; | ||
+ | top: 5px; | ||
+ | left: 27px; | ||
+ | border: 5px solid #385e66; | ||
+ | cursor: pointer; } | ||
+ | .path-btns .path-dot.active { | ||
+ | background-color: #385e66; } | ||
+ | .path-btns .path-dot:hover { | ||
+ | transition: all .3s; | ||
+ | transform: scale(1.2); } | ||
+ | |||
+ | |||
+ | .path { | ||
+ | height: 100px; | ||
+ | display: flex; } | ||
+ | .path .pathSvg { | ||
+ | display: block; } | ||
+ | .path .pathWord { | ||
+ | padding-right: 10%; } | ||
+ | .path .path-btn { | ||
+ | cursor: pointer; | ||
+ | fill: #fff; } | ||
+ | .path .path-btn.path-active { | ||
+ | fill: #385e66; } | ||
+ | .path .path-word-sm { | ||
+ | font-size: 12px; } | ||
+ | #HQ_page .path .pathWord p { | ||
+ | font-weight: 700; | ||
+ | text-align: left !important; | ||
+ | font-size: 16px; | ||
+ | } | ||
+ | #HQ_page .text-area p { | ||
+ | font-size: 22px; | ||
+ | font-family: 'Ubuntu'; | ||
+ | font-weight: 500; } | ||
+ | img.center { | ||
+ | display: block; | ||
+ | margin: 0 auto; } | ||
+ | |||
+ | .text-area h2{ | ||
+ | text-align: center; | ||
+ | margin-bottom: 2rem !important; | ||
+ | margin-top: 2rem; | ||
+ | color: black !important; | ||
+ | font-size: 40px; | ||
+ | font-weight:bold; | ||
+ | font-family:serif; | ||
+ | } | ||
+ | .text-area h3{ | ||
+ | text-align: left; | ||
+ | margin-bottom: 2rem !important; | ||
+ | margin-top: 2rem; | ||
+ | color: #4682B4 !important; | ||
+ | font-size: 28px; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | .text-area h4{ | ||
+ | text-align: left; | ||
+ | margin-bottom: 2rem !important; | ||
+ | margin-top: 2rem; | ||
+ | color: #f9000c !important; | ||
+ | font-size: 30px; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | |||
+ | .text-area h5{ | ||
+ | text-align: center; | ||
+ | margin-bottom: 2rem !important; | ||
+ | margin-top: 2rem; | ||
+ | color: #f9000c !important; | ||
+ | font-size: 30px; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | |||
+ | .top { | ||
+ | position: fixed; | ||
+ | right: 50px; | ||
+ | bottom: 50px; | ||
+ | height: 50px; | ||
+ | width: 50px; | ||
+ | cursor: pointer; } | ||
+ | .top img { | ||
+ | width: 100%; } | ||
+ | img.pic { | ||
+ | display: block !important; | ||
+ | margin: 40px auto !important; | ||
+ | } | ||
+ | |||
+ | .top-picture{ | ||
+ | z-index:2; | ||
+ | width:100%; | ||
+ | position: absolute; | ||
+ | } | ||
+ | |||
+ | video { | ||
+ | position:relative; | ||
+ | width: 100%; | ||
+ | height:auto; | ||
+ | margin: 20px auto !important; | ||
+ | } | ||
+ | </style> | ||
+ | |||
+ | <body> | ||
+ | <img class="top-picture" src="https://static.igem.org/mediawiki/2018/9/90/T--Mingdao--Phil13-2.png" > | ||
+ | <div class="bg-container" style="max-height:none;"> | ||
+ | |||
+ | <div class="my-main-container"> | ||
+ | <div class="main-content"> | ||
+ | <div class="text-area"> | ||
+ | |||
+ | <h2 id="d-intro"> </h2> | ||
+ | |||
+ | |||
+ | <p style="text-indent:2em"> | ||
+ | Mosquito Toll-Amp signaling plays an important roll in response to and regulating blood infectious pathogens. | ||
</p> | </p> | ||
− | </div> | + | <br /> |
+ | <p style="text-indent:2em"> | ||
+ | To genetically engineer mosquitoes as blood testing tools, we’ve collected DNA materials as BioBrick parts for future assembly. | ||
+ | </p> | ||
+ | <br /> | ||
+ | <p style="text-indent:2em"> | ||
+ | First, we designed a universal pathogen blood testing kit consisting of BioBrick parts of GAM1 promoter, GFP and polyA, as well as Ac5 promoter as a positive expression control. | ||
+ | </p> | ||
+ | <br /> | ||
+ | <p style="text-indent:2em"> | ||
+ | Second, we designed a HIV viral blood testing kit consisting of BioBrick parts of Ac5 promoter, CD4 extracellular domain, Drosophila transmembrane and intracellular domains, and poly A, as well as Ac5-GFP-polyA as a positive expression control. | ||
+ | </p> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/f/f0/T--Mingdao--phil14-2.png" alt="" style="width: 100%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/3/38/T--Mingdao--phil14-3.png" alt="" style="width: 80%; margin-bottom: 20px;"> | ||
+ | <br /> | ||
+ | <br /><br /> | ||
+ | <h5 id="d-kit1">UNIVERSAL PATHOGEN BLOOD TESTING KIT I</h5> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/2/2f/T--Mingdao--phil14-4.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/a/a0/T--Mingdao--phil13M1.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/c/c7/T--Mingdao--phil14-9.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/b/bd/T--Mingdao--phil14-10.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/f/f9/T--Mingdao--phil14-11.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/6/60/T--Mingdao--phil14-12.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <h5 id="d-kit2">HUMAN HIV VIRUS BLOOD TESTING KIT II</h5> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/6/6c/T--Mingdao--phil14-13.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/d/db/T--Mingdao--phil14-14.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/e/e5/T--Mingdao--phil14-15.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/2/29/T--Mingdao--phil14-16.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/7/70/T--Mingdao--phil14-17.png" alt="" style="width: 70%; margin-bottom: 20px;"> | ||
+ | <br /><br /> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="path-btns" style="left:0;"> | ||
+ | <div class="path"> | ||
+ | <div class="pathSvg"> | ||
+ | <svg width="80" height = "100"> | ||
+ | <rect x ="36" y="20" width="6" height="80" style="fill:#385e66"/> | ||
+ | </svg> | ||
+ | </div> | ||
+ | <div id="intro-btn" class="path-dot"></div> | ||
+ | <div class="pathWord path-word-sm"> | ||
+ | <p>Introduction</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="path"> | ||
+ | <div class="pathSvg"> | ||
+ | <svg width="80" height = "100"> | ||
+ | <rect x ="36" y="20" width="6" height="80" style="fill:#385e66"/> | ||
+ | </svg> | ||
+ | </div> | ||
+ | <div id="kit1-btn" class="path-dot" style="top: 100px"></div> | ||
+ | <div class="pathWord path-word-sm"> | ||
+ | <p>Kit 1</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="path"> | ||
+ | <div class="pathSvg"> | ||
+ | <svg width="80" height = "100"> | ||
+ | <rect x ="36" y="20" width="0" height="80" style="fill:#385e66"/> | ||
+ | </svg> | ||
+ | </div> | ||
+ | <div id="kit2-btn" class="path-dot" style="top: 200px"></div> | ||
+ | <div class="pathWord path-word-sm"> | ||
+ | <p>Kit 2</p> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | <div class="top"> | ||
+ | <img class="center" src="https://static.igem.org/mediawiki/2018/5/58/T--Mingdao--go_to_top.jpg" alt=""> | ||
+ | </div> | ||
+ | |||
+ | </body> | ||
+ | <script type="text/javascript"> | ||
+ | $("#intro-btn").click(function() { | ||
+ | $('html, body').animate({ | ||
+ | scrollTop: $("#d-intro").offset().top | ||
+ | }, 400); | ||
+ | }); | ||
+ | $("#kit1-btn").click(function() { | ||
+ | $('html, body').animate({ | ||
+ | scrollTop: $("#d-kit1").offset().top | ||
+ | }, 400); | ||
+ | }); | ||
+ | $("#kit2-btn").click(function() { | ||
+ | $('html, body').animate({ | ||
+ | scrollTop: $("#d-kit2").offset().top | ||
+ | }, 400); | ||
+ | }); | ||
+ | |||
+ | $(document).ready(function(){ | ||
+ | $('.top').on('click', function(){ | ||
+ | $('html, body').animate({scrollTop: '0px'}, 400); | ||
+ | }); | ||
+ | $("#intro-btn").css('background-color', '#385e66'); | ||
+ | var scroll_pos = 0; | ||
+ | $(document).scroll(function() { | ||
+ | scroll_pos = $(this).scrollTop(); | ||
+ | d_intro_pos = $("#d-intro").offset().top -100 | ||
+ | d_k1_pos = $("#d-kit1").offset().top -100 | ||
+ | d_k2_pos= $("#d-kit2").offset().top -100 | ||
− | < | + | // introduction |
− | + | if(scroll_pos < d_k1_pos) { | |
− | + | $(".path-dot").css('background-color', '#fff') | |
− | < | + | $("#intro-btn").css('background-color', '#385e66');} |
− | + | // model1 | |
− | + | else if(scroll_pos < d_k2_pos){ | |
+ | if(scroll_pos >= d_k1_pos){ | ||
+ | $(".path-dot").css('background-color', '#fff') | ||
+ | $("#kit1-btn").css('background-color', '#385e66');} | ||
+ | } | ||
+ | |||
+ | // conclusion | ||
+ | else if( scroll_pos >= d_k2_pos) { | ||
+ | $(".path-dot").css('background-color', '#fff') | ||
+ | $("#kit2-btn").css('background-color', '#385e66'); | ||
+ | } | ||
+ | }); | ||
+ | }); | ||
− | + | </script> | |
− | + | ||
− | + | ||
− | </ | + | |
</html> | </html> | ||
+ | {{:Team:Mingdao/test6}} |
Latest revision as of 03:34, 18 October 2018
Mosquito Toll-Amp signaling plays an important roll in response to and regulating blood infectious pathogens.
To genetically engineer mosquitoes as blood testing tools, we’ve collected DNA materials as BioBrick parts for future assembly.
First, we designed a universal pathogen blood testing kit consisting of BioBrick parts of GAM1 promoter, GFP and polyA, as well as Ac5 promoter as a positive expression control.
Second, we designed a HIV viral blood testing kit consisting of BioBrick parts of Ac5 promoter, CD4 extracellular domain, Drosophila transmembrane and intracellular domains, and poly A, as well as Ac5-GFP-polyA as a positive expression control.
UNIVERSAL PATHOGEN BLOOD TESTING KIT I
HUMAN HIV VIRUS BLOOD TESTING KIT II
Introduction
Kit 1
Kit 2